Annonce • Aug 04
Marlowe plc Announces Board Changes, Effective 4 August 2025 As the Scheme has now become Effective, Marlowe plc announced that, as of 4 August 2025, Lord Ashcroft KCMG PC, Adam Councell, Rachel Addison, Gillian Kent, Peter Gaze and Julia Robertson have stepped down from the Marlowe Board, and Peter Dickinson, Katherine Woods, Matthew Peacock and Peter Young have been appointed to the Marlowe Board. Annonce • Jun 25
Marlowe Expects Cancelation of Shares Listing from AIM On 5 June 2025, the boards of directors of Marlowe plc and Mitie Group Plc announced that they had reached agreement on the terms and conditions of a recommended cash and shares acquisition pursuant to which Bidco will acquire the entire issued, and to be issued, ordinary share capital of Marlowe (the "Acquisition"). It is intended that the Acquisition will be effected by means of a scheme of arrangement under Part 26 of the Companies Act 2006 (the "Scheme"). The circular in relation to the Scheme (the "Scheme Document") was published and posted to Marlowe Shareholders on 23 June 2025. Expected Sanction Hearing (as soon as reasonably practicable after Bidco confirms the satisfaction or waiver of the Conditions (other than Conditions 1 and 2(c))("D")). Expected Suspension of dealings in Company Shares on AIM: 7.30 a.m. on D+2 Business Days. Expected Cancellation of listing of Company Shares from AIM by 7.00 a.m. on D+3 Business Days. Annonce • Apr 28
Marlowe plc (AIM:MRL) acquired Sludge Tek Holdings Limited for £6.2 million. Marlowe plc (AIM:MRL) acquired Sludge Tek Holdings Limited for £6.2 million on April 28, 2025. The consideration for the acquisition consists of an initial payment of £5.7 million, and deferred consideration of an estimated £0.5 million based on the completion of certain post-acquisition performance targets objectives. Ben Jeynes and George Lawson of Cavendish Capital Markets Limited acted as financial advisor to Marlowe plc.
Marlowe plc (AIM:MRL) completed the acquisition of Sludge Tek Holdings Limited on April 28, 2025. New Risk • Apr 28
New major risk - Revenue and earnings growth Earnings are forecast to decline by an average of 40% per year for the foreseeable future. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If profits are expected to decline, then in most cases the share price will decline over time as well. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. Currently, the following risks have been identified for the company: Major Risk Earnings are forecast to decline by an average of 40% per year for the foreseeable future. Minor Risk Less than 1 year of cash runway based on current free cash flow (-UK£38m). Price Target Changed • Dec 09
Price target decreased by 12% to UK£3.92 Down from UK£4.47, the current price target is an average from 6 analysts. New target price is 23% above last closing price of UK£3.20. Stock is down 3.9% over the past year. The company is forecast to post earnings per share of UK£0.03 next year compared to a net loss per share of UK£0.14 last year. New Risk • Dec 06
New minor risk - Financial position The company has less than a year of cash runway based on its current free cash flow. Free cash flow: -UK£38m This is considered a minor risk. With less than a year's worth of cash, the company will need to raise capital or take on debt unless its cash flows improve. This would dilute existing shareholders or increase balance sheet risk. Currently, the following risks have been identified for the company: Major Risk Share price has been highly volatile over the past 3 months (11% average weekly change). Minor Risk Less than 1 year of cash runway based on current free cash flow (-UK£38m). Reported Earnings • Dec 06
First half 2025 earnings released: UK£0.036 loss per share (vs UK£0.096 loss in 1H 2024) First half 2025 results: UK£0.036 loss per share (improved from UK£0.096 loss in 1H 2024). Revenue: UK£220.4m (down 12% from 1H 2024). Net loss: UK£3.40m (loss narrowed 63% from 1H 2024). Revenue is expected to decline by 1.5% p.a. on average during the next 3 years, while revenues in the Professional Services industry in the United Kingdom are expected to grow by 6.1%. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 63 percentage points per year, which is a significant difference in performance. Annonce • Dec 05
Marlowe plc to Report First Half, 2025 Results on Dec 05, 2024 Marlowe plc announced that they will report first half, 2025 results on Dec 05, 2024 Recent Insider Transactions • Oct 02
Independent Non-Executive Director recently bought UK£92k worth of stock On the 27th of September, Peter Michael Gaze bought around 30k shares on-market at roughly UK£3.08 per share. This transaction amounted to 5.0% of their direct individual holding at the time of the trade. This was the largest purchase by an insider in the last 3 months. This was the only on-market transaction from insiders over the last 12 months. Price Target Changed • Sep 27
Price target decreased by 8.8% to UK£5.28 Down from UK£5.79, the current price target is an average from 7 analysts. New target price is 68% above last closing price of UK£3.15. Stock is down 46% over the past year. The company posted a net loss per share of UK£0.14 last year. Buy Or Sell Opportunity • Sep 24
Now 21% undervalued Over the last 90 days, the stock has risen 11% to UK£4.80. The fair value is estimated to be UK£6.10, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 28% over the last 3 years. Earnings per share has declined by 101%. Price Target Changed • Sep 12
Price target decreased by 15% to UK£5.79 Down from UK£6.81, the current price target is an average from 6 analysts. New target price is 35% above last closing price of UK£4.30. Stock is down 28% over the past year. The company is forecast to post earnings per share of UK£0.093 next year compared to a net loss per share of UK£0.14 last year. Annonce • Aug 10
Marlowe plc, Annual General Meeting, Sep 30, 2024 Marlowe plc, Annual General Meeting, Sep 30, 2024. Location: 4th floor, 20 grosvenor place, sw1x 7hn, london United Kingdom Reported Earnings • Jul 24
Full year 2024 earnings: EPS and revenues exceed analyst expectations Full year 2024 results: UK£0.14 loss per share (further deteriorated from UK£0.04 loss in FY 2023). Revenue: UK£402.9m (down 14% from FY 2023). Net loss: UK£13.7m (loss widened 261% from FY 2023). Revenue exceeded analyst estimates by 25%. Earnings per share (EPS) also surpassed analyst estimates by 19%. Revenue is forecast to grow 3.9% p.a. on average during the next 3 years, compared to a 5.8% growth forecast for the Professional Services industry in the United Kingdom. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 83 percentage points per year, which is a significant difference in performance. Annonce • Jul 20
Marlowe plc to Report Fiscal Year 2024 Results on Jul 23, 2024 Marlowe plc announced that they will report fiscal year 2024 results at 8:00 AM, GMT Standard Time on Jul 23, 2024 Board Change • Jul 01
High number of new and inexperienced directors There are 5 new directors who have joined the board in the last 3 years. The company's board is composed of: 5 new directors. No experienced directors. 1 highly experienced director. Independent Non-Executive Director Peter Michael Gaze is the most experienced director on the board, commencing their role in 2006. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of board continuity. Lack of experienced directors. Board Change • Jun 09
High number of new and inexperienced directors There are 4 new directors who have joined the board in the last 3 years. The company's board is composed of: 4 new directors. No experienced directors. 1 highly experienced director. Independent Non-Executive Director Peter Michael Gaze is the most experienced director on the board, commencing their role in 2006. The company’s lack of experienced directors is considered a risk according to the Simply Wall St Risk Model. Board Change • Mar 22
Less than half of directors are independent Following the recent departure of a director, there are only 3 independent directors on the board. The company's board is composed of: 3 independent directors. 4 non-independent directors. Independent Non-Executive Director Gillian D. Kent was the last independent director to join the board, commencing their role in 2022. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model. Buy Or Sell Opportunity • Mar 21
Now 21% overvalued after recent price rise Over the last 90 days, the stock has risen 29% to UK£5.40. The fair value is estimated to be UK£4.46, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has grown by 37% over the last 3 years. Meanwhile, the company became loss making. Annonce • Mar 20
Marlowe plc Announces Director Changes Marlowe plc announced the following changes to its Board: the appointment of Lord Ashcroft KCMG PC as a Non-Executive Director. Charles Skinner is stepping down from the Marlowe Board, having been in role since the company's formation and through to its growth into the UK leader in business-critical services and software. Charles will be replaced by a new Independent Non-Executive Director in due course. Price Target Changed • Feb 23
Price target decreased by 7.4% to UK£7.98 Down from UK£8.62, the current price target is an average from 5 analysts. New target price is 59% above last closing price of UK£5.02. Stock is up 14% over the past year. The company is forecast to post a net loss per share of UK£0.13 next year compared to a net loss per share of UK£0.04 last year. Price Target Changed • Feb 02
Price target decreased by 7.8% to UK£8.48 Down from UK£9.21, the current price target is an average from 6 analysts. New target price is 129% above last closing price of UK£3.70. Stock is down 26% over the past year. The company is forecast to post a net loss per share of UK£0.086 next year compared to a net loss per share of UK£0.04 last year. Reported Earnings • Nov 30
First half 2024 earnings released: UK£0.096 loss per share (vs UK£0.011 profit in 1H 2023) First half 2024 results: UK£0.096 loss per share (down from UK£0.011 profit in 1H 2023). Revenue: UK£251.3m (up 13% from 1H 2023). Net loss: UK£9.20m (down UK£10.3m from profit in 1H 2023). Revenue is forecast to grow 8.3% p.a. on average during the next 3 years, compared to a 5.7% growth forecast for the Professional Services industry in the United Kingdom. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 77 percentage points per year, which is a significant difference in performance. Price Target Changed • Nov 28
Price target decreased by 12% to UK£8.15 Down from UK£9.25, the current price target is an average from 5 analysts. New target price is 101% above last closing price of UK£4.05. Stock is down 23% over the past year. The company is forecast to post earnings per share of UK£0.081 next year compared to a net loss per share of UK£0.04 last year. Annonce • Nov 24
Marlowe plc to Report First Half, 2024 Results on Nov 28, 2023 Marlowe plc announced that they will report first half, 2024 results on Nov 28, 2023 Annonce • Jul 27
Marlowe plc (AIM:MRL) acquired International Management Systems Marketing Ltd. for an enterprise value of £17.4 million. Marlowe plc (AIM:MRL) acquired International Management Systems Marketing Ltd. for an enterprise value of £17.4 million on July 26, 2023. The total enterprise value will comprise an upfront cash consideration of £12.9 million and a further £3 million payment through the issue of 597,609 ordinary shares of 50 pence each in the capital of the Company ("Consideration Shares") in addition to an estimated £1.5 million in performance-related contingent consideration payable after the first year of ownership. The Consideration Shares are being issued to the vendor and are locked in for a period of two years. For FY ended 2022, IMSM generated revenues of £12.2 million and EBITDA of £1.9 million. Cenkos Securities plc acted as nominated advisor and joint broker, Stifel and Berenberg acted as joint brokers and FTI Consulting acted as adviser to Marlowe in this transaction.
Marlowe plc (AIM:MRL) completed the acquisition of International Management Systems Marketing Ltd. on July 26, 2023. Annonce • Jul 14
Marlowe plc, Annual General Meeting, Sep 13, 2023 Marlowe plc, Annual General Meeting, Sep 13, 2023, at 09:00 Coordinated Universal Time. Location: 20 Grosvenor Place London, SW1X 7HN London United Kingdom Buying Opportunity • Jul 01
Now 23% undervalued after recent price drop Over the last 90 days, the stock is down 3.4%. The fair value is estimated to be UK£7.24, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 37% over the last 3 years. Meanwhile, the company became loss making. Reported Earnings • Jun 30
Full year 2023 earnings: EPS and revenues miss analyst expectations Full year 2023 results: UK£0.04 loss per share (down from UK£0.009 profit in FY 2022). Revenue: UK£465.7m (up 47% from FY 2022). Net loss: UK£3.80m (down UK£4.50m from profit in FY 2022). Revenue missed analyst estimates by 1.8%. Earnings per share (EPS) were also behind analyst expectations. Revenue is forecast to grow 9.0% p.a. on average during the next 3 years, compared to a 6.0% growth forecast for the Professional Services industry in the United Kingdom. Over the last 3 years on average, earnings per share has fallen by 16% per year but the company’s share price has increased by 5% per year, which means it is well ahead of earnings. Annonce • Jun 26
Marlowe plc to Report Fiscal Year 2023 Results on Jun 29, 2023 Marlowe plc announced that they will report fiscal year 2023 results on Jun 29, 2023 Annonce • Jun 17
Marlowe Reportedly Explores Sale of Inspection Unit Marlowe Plc (LON:MRL) is looking to divest its testing, inspection and certification (TIC) unit for about GBP 650 million (USD 822m/EUR 760m), SkyNews reported. According to the report, Marlowe has appointed Rothschild to explore the sale of its largest unit. A potential deal could value the subsidiary at up to 16 times its yearly profit, the news channel said, citing estimates based on deals in the sector. According to SkyNews' sources, early talks with potential suitors for the business are ongoing. TIC covers services like fire safety and security and water and air hygiene. Marlowe's other division is governance, risk and compliance, which includes services like health and Safety, employment law and HR and occupational health. Shares in Marlowe were trading at 665 pence in afternoon trading on Friday, up 12.33% on the day. Price Target Changed • Jun 08
Price target decreased by 11% to UK£9.97 Down from UK£11.24, the current price target is an average from 5 analysts. New target price is 71% above last closing price of UK£5.82. Stock is down 36% over the past year. The company is forecast to post earnings per share of UK£0.021 for next year compared to UK£0.0085 last year. Major Estimate Revision • Nov 30
Consensus forecasts updated The consensus outlook for 2023 has been updated. 2023 revenue forecast increased from UK£436.2m to UK£463.8m. Now expected to report loss of -UK£0.01 instead of UK£0.14 per share profit. Commercial Services industry in the United Kingdom expected to see average net income growth of 13% next year. Consensus price target down from UK£11.24 to UK£10.77. Share price fell 19% to UK£4.97 over the past week. Recent Insider Transactions • Nov 27
Independent Non-Executive Director recently bought UK£100k worth of stock On the 24th of November, Charles Skinner bought around 17k shares on-market at roughly UK£6.04 per share. This transaction amounted to 3.3% of their direct individual holding at the time of the trade. This was the largest purchase by an insider in the last 3 months. Insiders have collectively bought UK£537k more in shares than they have sold in the last 12 months. Reported Earnings • Nov 24
First half 2023 earnings released: EPS: UK£0.011 (vs UK£0.017 in 1H 2022) First half 2023 results: EPS: UK£0.011 (down from UK£0.017 in 1H 2022). Revenue: UK£222.9m (up 66% from 1H 2022). Net income: UK£1.10m (down 15% from 1H 2022). Profit margin: 0.5% (down from 1.0% in 1H 2022). Revenue is forecast to grow 7.6% p.a. on average during the next 3 years, compared to a 11% growth forecast for the Commercial Services industry in the United Kingdom. Over the last 3 years on average, earnings per share has fallen by 8% per year but the company’s share price has increased by 10% per year, which means it is well ahead of earnings. Buying Opportunity • Aug 22
Now 22% undervalued after recent price drop Over the last 90 days, the stock is down 22%. The fair value is estimated to be UK£9.02, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 25% over the last 3 years. Meanwhile, the company has become profitable. For the next 3 years, revenue is forecast to grow by 11% per annum. Earnings is also forecast to grow by 54% per annum over the same time period. Reported Earnings • Jun 29
Full year 2022 earnings: EPS and revenues exceed analyst expectations Full year 2022 results: EPS: UK£0.009 (up from UK£0.031 loss in FY 2021). Revenue: UK£315.9m (up 65% from FY 2021). Net income: UK£700.0k (up UK£2.40m from FY 2021). Profit margin: 0.2% (up from net loss in FY 2021). Revenue exceeded analyst estimates by 3.0%. Earnings per share (EPS) also surpassed analyst estimates. Over the next year, revenue is forecast to grow 38%, compared to a 14% growth forecast for the industry in the United Kingdom. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 107 percentage points per year, which is a significant difference in performance. Buying Opportunity • Jun 17
Now 20% undervalued The stock has been flat over the last 90 days. The fair value is estimated to be UK£9.90, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 23% over the last 3 years. Meanwhile, the company became loss making. Buying Opportunity • May 09
Now 21% undervalued after recent price drop Over the last 90 days, the stock is down 9.8%. The fair value is estimated to be UK£9.81, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 23% over the last 3 years. Meanwhile, the company became loss making. Board Change • Apr 27
Less than half of directors are independent Following the recent departure of a director, there are only 2 independent directors on the board. The company's board is composed of: 2 independent directors. 4 non-independent directors. Independent Non-Executive Director Charles Anthony Skinner was the last independent director to join the board, commencing their role in 2015. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model. Buying Opportunity • Mar 14
Now 22% undervalued after recent price drop Over the last 90 days, the stock is down 17%. The fair value is estimated to be UK£9.69, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 23% per annum over the last 3 years. The company became loss making over the last year. Recent Insider Transactions • Jan 27
CEO & Director recently bought UK£200k worth of stock On the 20th of January, Alex Dacre bought around 20k shares on-market at roughly UK£10.00 per share. This was the largest purchase by an insider in the last 3 months. Despite this recent buy, Alex has been a net seller over the last 12 months, reducing personal holdings by UK£2.8m. Reported Earnings • Dec 03
First half 2022 earnings: EPS and revenues miss analyst expectations First half 2022 results: EPS: UK£0.017 (up from UK£0.01 in 1H 2021). Revenue: UK£134.5m (up 62% from 1H 2021). Net income: UK£1.30m (up 160% from 1H 2021). Profit margin: 1.0% (up from 0.6% in 1H 2021). Revenue missed analyst estimates by 5.2%. Earnings per share (EPS) also missed analyst estimates by 201%. Earnings per share (EPS) missed analyst estimates by 201%. Over the next year, revenue is forecast to grow 32%, compared to a 8.0% growth forecast for the industry in the United Kingdom. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 112 percentage points per year, which is a significant difference in performance. Reported Earnings • Jun 27
Full year 2021 earnings released: UK£0.031 loss per share (vs UK£0.009 loss in FY 2020) The company reported a soft full year result with increased losses and weaker control over costs, although revenues improved. Full year 2021 results: Revenue: UK£192.0m (up 3.6% from FY 2020). Net loss: UK£1.70m (loss widened 325% from FY 2020). Over the last 3 years on average, earnings per share has fallen by 18% per year but the company’s share price has increased by 24% per year, which means it is well ahead of earnings. Price Target Changed • Jun 24
Price target increased to UK£10.22 Up from UK£8.23, the current price target is an average from 5 analysts. New target price is 20% above last closing price of UK£8.54. Stock is up 79% over the past year. Major Estimate Revision • May 11
Consensus forecasts updated The consensus outlook for 2021 has been updated. Forecast profits in 2021 with EPS up from -UK£0.011 to UK£0.031 per share. Revenue forecast unchanged from last update at UK£202.6m. Commercial Services industry in the United Kingdom expected to see average net income growth of 30% next year. Consensus price target up from UK£7.77 to UK£8.31. Share price fell 2.6% to UK£7.60 over the past week. Recent Insider Transactions • Mar 27
CEO & Director recently sold UK£3.0m worth of stock On the 25th of March, Alex Dacre sold around 440k shares on-market at roughly UK£6.90 per share. This was the largest sale by an insider in the last 3 months. Alex has been a seller over the last 12 months, reducing personal holdings by UK£3.0m. Annonce • Mar 21
Marlowe plc has completed a Follow-on Equity Offering in the amount of £100.000003 million. Marlowe plc has completed a Follow-on Equity Offering in the amount of £100.000003 million.
Security Name: Ordinary Shares
Security Type: Common Stock
Securities Offered: 14,492,754
Price\Range: £6.9
Transaction Features: Regulation S; Subsequent Direct Listing Annonce • Feb 26
Marlowe plc Announces Executive Changes Marlowe plc announced that Adam Councell will be appointed as Chief Financial Officer of the Group to succeed Mark Adams, who has indicated his intention to retire. Following an orderly handover, Mark is expected to retire shortly after Adam's appointment to the Board, which is intended to occur during the second half of the Group's FY22 financial year. Adam is currently CFO of Fuller, Smith & Turner plc, the pub and hotels business. From 2012 until 2019 he was CFO of Restore plc, where he played a leading role in the development of the group into a leading office services provider. Prior to Restore, Adam spent nine years at Rentokil Initial plc. Major Estimate Revision • Feb 19
Analysts update estimates The company's losses in 2021 are expected to worsen with analysts lowering their consensus EPS forecasts from -UK£0.008 to -UK£0.01. Revenue estimate was approximately flat at UK£201.0m. The Commercial Services industry in the United Kingdom is expected to see a 15% decline in net income next year. The consensus price target increased from UK£6.71 to UK£7.60. Share price is up 15% to UK£6.87 over the past week. Is New 90 Day High Low • Feb 18
New 90-day high: UK£7.16 The company is up 31% from its price of UK£5.45 on 19 November 2020. The British market is up 7.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Commercial Services industry, which is up 7.0% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is UK£8.04 per share. Annonce • Feb 05
Marlowe plc (AIM:MRL) acquired Hadrian Technology Limited for an enterprise value of £3.8 million. Marlowe plc (AIM:MRL) acquired Hadrian Technology Limited for an enterprise value of £3.8 million on February 4, 2021. The total enterprise value will comprise an upfront cash consideration of £2.0 million and a contingent consideration which is expected to be approximately £1.8 million over four years dependent on the achievement of profit targets. The transaction will be funded from Marlowe's existing cash resources. Nicholas Wells and Ben Jeynes of Cenkos Securities plc (AIM:CNKS) acted as financial advisor to Marlowe plc.
Marlowe plc (AIM:MRL) completed the acquisition of Hadrian Technology Limited on February 4, 2021. Price Target Changed • Jan 27
Price target raised to UK£6.71 Up from UK£6.27, the current price target is an average from 4 analysts. The new target price is 11% above the current share price of UK£6.04. As of last close, the stock is up 23% over the past year. Annonce • Jan 08
Marlowe plc (AIM:MRL) acquired WPL Limited for £10 million. Marlowe plc (AIM:MRL) acquired WPL Limited for £10 million on January 7, 2021. The total consideration of £10.0 million comprises a cash payment of £9.1 million and the issue of 147,652 new ordinary shares in Marlowe. The Consideration Shares are subject to a two year lock-in. As of October 31, 2019, WPL Limited reported a net asset of £4.5 million. Nicholas Wells and Ben Jeynes of Cenkos Securities plc (AIM:CNKS) acted as financial advisor for Marlowe.
Marlowe plc (AIM:MRL) completed the acquisition of WPL Limited on January 7, 2021.